Atellica CH Systems Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement of glycated protein (fructosamine) in human serum or plasma on the ADVIA® Chemistry systems Siemens Material Number (SMN): 11097637
Published October 21, 2020 · Recall initiated: September 22, 2020
Summary
FDA records medical device Class II recall Z-0102-2021, published October 21, 2020 and initiated September 22, 2020. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Ongoing; Reported quantity: US: 28; OUS: 255 units; Lot: All lots UDI: (01)00630414595580(10)201115(17)20210201 (01)00630414595580(10)201207(17)20210601. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Fructosamine QC and patient samples may exhibit a 60 umol/L positive bias across the measuring range compared to predicate assay reference leading to a potential adjustment of hyperglycemic therapy. Positively biased fructosamine results may prompt changes in glucose management that may affect glycemia. In extreme situations, more aggressive management of glycemia may occur and contribute to hypoglycemia.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Siemens Healthcare Diagnostics, Inc.
- Distributor
- CA, DE, MD, NC, NJ, NY, PA Foreign: Argentina®¿¿¿¿¿ Australia®¿¿¿¿¿ Brazil®¿¿¿ Canada®¿¿¿¿ Czech®Republic® Denmark®¿¿¿¿¿¿¿ Germany®¿¿¿¿¿¿¿ Italy®¿¿¿¿¿¿¿¿¿ Netherlands®¿¿¿ P.R.¿China®¿¿¿¿ Paraguay®¿¿¿¿¿¿ Slovakia®¿¿¿¿¿¿ Turkey®¿¿¿¿¿¿¿¿ United®Kingdom® Vietnam®¿¿¿¿¿¿¿
- Lot
- All lots UDI: (01)00630414595580(10)201115(17)20210201 (01)00630414595580(10)201207(17)20210601
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAtellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;October 7, 2026
- FDABeckman Coulter, Emit 2000 Quinidine Assay REF: OSR4Q229 Contents: R1: 2 x 23 mL;R2 2x13 mLAugust 26, 2026
- FDASyva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mLAugust 26, 2026
- FDASyva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls SMN 10445390 Catalog No. 7C219ULAugust 12, 2026
- FDAADVIA Chemistry Systems-Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement ofOctober 21, 2020
- FDAAlbumin Gen.2, Catalog 05166861190October 21, 2020
Questions about this recall
Was Atellica CH Systems Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement of glycated protein (fructosamine) in human serum or plasma on the ADVIA® Chemistry systems Siemens Material Number (SMN): 11097637 recalled?
Yes. FDA published recall Z-0102-2021 on October 21, 2020. Reported hazard: Fructosamine QC and patient samples may exhibit a 60 umol/L positive bias across the measuring range compared to predicate assay reference leading to a potential adjustment of hyperglycemic therapy. Positively biased fructosamine results may prompt changes in glucose management that may affect glycemia. In extreme situations, more aggressive management of glycemia may occur and contribute to hypoglycemia.
What should I do if I have this product?
Voluntary: Firm initiated · Letter